Popular New
- Copy number alterations define outcome in Philadelphia chromosomepositive acute lymphoblastic leukemia50 daysPorkka, K(immo)*Read
- Incidence of myelodysplastic syndromes in Finland 1997-201650 daysPorkka, K(immo)*Read
- Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia50 daysPorkka, K(immo)*Read
- Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status50 daysPorkka, K(immo)*Read
- Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia50 daysPorkka, K(immo)*Read
- Genome-wide association study identifies susceptibility loci for acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS50 daysPorkka, K(immo)*Read
- Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial50 daysPorkka, K(immo)*Read
- Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia50 daysPorkka, K(immo)*Read
- New insight to the role of microbes in the methane exchange in trees: evidence from metagenomic sequencing50 daysPorkka, K(immo)*Read
- The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study50 daysPorkka, K(immo)*Read
- Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial50 daysPorkka, K(immo)*Read
- Patient-tailored design for selective co-inhibition of leukemic cell subpopulations50 daysPorkka, K(immo)*Read
- Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission50 daysPorkka, K(immo)*Read
- Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets50 daysPorkka, K(immo)*Read
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia50 daysPorkka, K(immo)*Read
- RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses50 daysPorkka, K(immo)*Read
- KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition50 daysPorkka, K(immo)*Read
- Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma50 daysPorkka, K(immo)*Read
- Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia50 daysPorkka, K(immo)*Read
- Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival50 daysPorkka, K(immo)*Read
- EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies50 daysPorkka, K(immo)*Read
- Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types50 daysPorkka, K(immo)*Read
- Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia50 daysPorkka, K(immo)*Read
- Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML50 daysPorkka, K(immo)*Read
- Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies50 daysPorkka, K(immo)*Read
- <em>ERCC6L2</em> defines a novel entity within inherited acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL50 daysPorkka, K(immo)*Read
- Dasatinib and navitoclax act synergistically to target NUP98-NSD1<sup>+</sup>/FLT3-ITD<sup>+</sup> acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment50 daysPorkka, K(immo)*Read
- Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML50 daysPorkka, K(immo)*Read
- Germline alterations in a consecutive series of acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemia50 daysPorkka, K(immo)*Read
- Applications of genomic medicine in the treatment of diseases50 daysPorkka, K(immo)*Read
- Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing50 daysPorkka, K(immo)*Read
- Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia50 daysPorkka, K(immo)*Read
- NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib50 daysPorkka, K(immo)*Read
- Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion50 daysPorkka, K(immo)*Read
- Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis50 daysPorkka, K(immo)*Read
- JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML50 daysPorkka, K(immo)*Read
- Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib50 daysPorkka, K(immo)*Read
- Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion50 daysPorkka, K(immo)*Read
- Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors50 daysPorkka, K(immo)*Read
- Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia50 daysPorkka, K(immo)*Read
- Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models50 daysPorkka, K(immo)*Read
- Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia50 daysPorkka, K(immo)*Read
- Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia50 daysPorkka, K(immo)*Read

Impact Factor: 11.461
SJR: 4.195
JUFO: 1.854
Articles: 50
Terkko Factor: 472.1 (√IF*SJR*JUFO * Num)
Based on articles published in the last 12 months.
Profile on PlumX
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology